Vera Therapeutics
VERA
VERA
229 hedge funds and large institutions have $2.92B invested in Vera Therapeutics in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 94 increasing their positions, 65 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
14.54% less ownership
Funds ownership: 115.77% → 101.23% (-15%)
22% less capital invested
Capital invested by funds: $3.75B → $2.92B (-$829M)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
229
Holding in Top 10
7
Calls
$42.9M
Puts
$3.47M
Top Buyers
| 1 | +$55.4M | |
| 2 | +$35.2M | |
| 3 | +$29.6M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$19.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$15.7M |
Top Sellers
| 1 | -$66.2M | |
| 2 | -$40.8M | |
| 3 | -$38.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$38.3M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$23.9M |
